Advanced Biliary Tract Cancer

25 clinical trials · Condition

Record	Firm	Date
Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment (NCT05170438)	National Health Research Institutes, Taiwan	2022-07-01
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers (NCT04781192)	University of Kansas Medical Center	2022-03-22
Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer (NCT05009953)	CSPC Ouyi Pharmaceutical Co., Ltd.	2021-09-01
A Phase 1/2 Study of SC-43 in Combination With Cisplatin (NCT04733521)	RaND Biosciences	2021-05-01
Phase II Study of Sitravatinib in Combination With Tislelizumab in Patients With Advanced Biliary Tract Cancer (NCT04727996)	Seoul National University Hospital	2020-11-01
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers (NCT04211168)	Peking Union Medical College Hospital	2020-08-11
HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC (NCT04217954)	Peking University	2020-07-28
NGS as the First-line Treatment in Advanced Biliary Tract Cancer (NCT04172402)	National Health Research Institutes, Taiwan	2019-12-27
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer (NCT04005339)	Georgetown University	2019-07-29
Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer (NCT04027764)	Dai, Guanghai	2019-05-01
A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 (NCT02597465)	Sun Pharma Advanced Research Company Limited	2018-12-01
Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer (NCT03358849)	Yonsei University	2017-10-17

Track Advanced Biliary Tract Cancer automatically

Every clearance here is in the API, with alerts when new ones post.